Suppr超能文献

人类多能干细胞、类器官和基因组编辑技术的融合。

Convergence of human pluripotent stem cell, organoid, and genome editing technologies.

机构信息

Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, MD 21218, USA.

出版信息

Exp Biol Med (Maywood). 2021 Apr;246(7):861-875. doi: 10.1177/1535370220985808. Epub 2021 Jan 19.

Abstract

The last decade has seen many exciting technological breakthroughs that greatly expanded the toolboxes for biological and biomedical research, yet few have had more impact than induced pluripotent stem cells and modern-day genome editing. These technologies are providing unprecedented opportunities to improve physiological relevance of experimental models, further our understanding of developmental processes, and develop novel therapies. One of the research areas that benefit greatly from these technological advances is the three-dimensional human organoid culture systems that resemble human tissues morphologically and physiologically. Here we summarize the development of human pluripotent stem cells and their differentiation through organoid formation. We further discuss how genetic modifications, genome editing in particular, were applied to answer basic biological and biomedical questions using organoid cultures of both somatic and pluripotent stem cell origins. Finally, we discuss the potential challenges of applying human pluripotent stem cell and organoid technologies for safety and efficiency evaluation of emerging genome editing tools.

摘要

过去十年见证了许多激动人心的技术突破,极大地扩展了生物学和生物医学研究的工具包,但很少有技术比诱导多能干细胞和现代基因组编辑产生更大的影响。这些技术为提高实验模型的生理相关性、深化我们对发育过程的理解以及开发新疗法提供了前所未有的机会。受益于这些技术进步的研究领域之一是三维人类类器官培养系统,它在形态和生理上类似于人类组织。在这里,我们总结了人类多能干细胞的发展及其通过类器官形成的分化。我们进一步讨论了如何应用遗传修饰,特别是基因组编辑,使用源自体细胞和多能干细胞的类器官培养物来回答基本的生物学和生物医学问题。最后,我们讨论了应用人类多能干细胞和类器官技术评估新兴基因组编辑工具的安全性和效率所面临的潜在挑战。

相似文献

2
Genome editing in pluripotent stem cells: research and therapeutic applications.多能干细胞中的基因组编辑:研究与治疗应用
Biochem Biophys Res Commun. 2016 May 6;473(3):665-74. doi: 10.1016/j.bbrc.2016.02.113. Epub 2016 Feb 27.
3
Organoid technologies meet genome engineering.类器官技术与基因组工程相遇。
EMBO Rep. 2017 Mar;18(3):367-376. doi: 10.15252/embr.201643732. Epub 2017 Feb 15.
8
Genome engineering of stem cell organoids for disease modeling.用于疾病建模的干细胞类器官基因组工程
Protein Cell. 2017 May;8(5):315-327. doi: 10.1007/s13238-016-0368-0. Epub 2017 Jan 19.

引用本文的文献

5
Editorial: Editor's Pick 2021: Highlights in Stem Cell Research.社论:2021年编辑推荐:干细胞研究亮点。
Front Cell Dev Biol. 2022 Mar 25;10:859472. doi: 10.3389/fcell.2022.859472. eCollection 2022.

本文引用的文献

3
Upgrading the Physiological Relevance of Human Brain Organoids.人脑类器官的生理相关性升级。
Neuron. 2020 Sep 23;107(6):1014-1028. doi: 10.1016/j.neuron.2020.08.029.
4
Are Organoids Ready for Prime Time?类器官是否已经准备好进入黄金时代?
Cell Stem Cell. 2020 Sep 3;27(3):361-365. doi: 10.1016/j.stem.2020.08.013.
5
SARS-CoV-2 targets neurons of 3D human brain organoids.SARS-CoV-2 靶向 3D 人脑组织类器官中的神经元。
EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.
6
Immune-evasive human islet-like organoids ameliorate diabetes.免疫逃避的人胰岛类器官改善糖尿病。
Nature. 2020 Oct;586(7830):606-611. doi: 10.1038/s41586-020-2631-z. Epub 2020 Aug 19.
9
Human organoids: model systems for human biology and medicine.人类类器官:人类生物学和医学的模型系统。
Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584. doi: 10.1038/s41580-020-0259-3. Epub 2020 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验